Capricor Therapeutics (CAPR) Change in Acquisitions & Divestments (2013 - 2026)

Capricor Therapeutics' Change in Acquisitions & Divestments history runs 13 years deep, the most recent figure standing at $31.0 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 28.27% year-over-year to $31.0 million; the TTM figure through Mar 2026 stood at $248.4 million (up 120.52% YoY), while the FY2025 annual figure was $260.6 million, up 177.83% from the prior year.
• Change in Acquisitions & Divestments was $31.0 million for Q1 2026 at Capricor Therapeutics, down from $63.2 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $78.2 million in Q3 2025 to a low of $14.0 million in Q2 2022.
• Historically, Change in Acquisitions & Divestments has averaged $35.8 million across 5 years, with a median of $30.5 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments tumbled 48.86% in 2023, then soared 278.14% in 2025.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $38.4 million in 2022, then plunged by 48.86% to $19.6 million in 2023, then declined by 14.89% to $16.7 million in 2024, then jumped by 278.14% to $63.2 million in 2025, then sank by 50.96% to $31.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $31.0 million (Q1 2026), $63.2 million (Q4 2025), and $78.2 million (Q3 2025), per Business Quant data.